JOHNSON KENNETH ERLAND
SEC CIK 1743774 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | See Remarks | 346.3K | — | — | 7 | 2021-10-05 | 2025-01-31 |
Most active insiders at XERS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hecht Beth | See Remarks | — | $1.31M |
| 2 | McCulloch Kevin | See Remarks | — | $1.09M |
| 3 | JOHNSON JOHN | Dir | — | $1.07M |
| 4 | Pieper Steven | See Remarks | — | $468.2K |
| 5 | Shannon John Patrick Jr | See Remarks, Dir | — | $349.7K |
| 6 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Dir | — | $203.9K |
| 7 | HALKUFF DAWN | Dir | — | $121.9K |
| 8 | PERSKY MARLA | Dir | — | $91.4K |
| 9 | Brady James Aloysius | Dir | — | $60.0K |
| 10 | Nguyen Anh Tu | See Remarks | — | — |
JOHNSON KENNETH ERLAND made no open-market trades at XERS in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-03 | 2025-01-31 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON KENNETH ERLAND | See Remarks | F - Tax | $3.56 | -41.3K | 346.3K | -11% | -$147.1K |
| 2025-01-07 | 2025-01-03 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON KENNETH ERLAND | See Remarks | F - Tax | $3.61 | -12.4K | 361.8K | -3% | -$44.8K | |
| M | 2024-08-09 | 2022-01-29+ | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON KENNETH ERLAND | See Remarks | F - Tax | $1.95 | -74.9K | 440.4K | -15% | -$146.3K |
| 2024-01-31 | 2024-01-31 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON KENNETH ERLAND | See Remarks | A - Grant | $0.00 | +175.0K | 446.9K | +64% | $0 | |
| 2023-02-01 | 2023-01-31 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON KENNETH ERLAND | See Remarks | A - Grant | $0.00 | +100.0K | 269.8K | +59% | $0 | |
| 2022-01-05 | 2022-01-03 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON KENNETH ERLAND | See Remarks | A - Grant | $0.00 | +75.0K | 165.9K | +83% | $0 | |
| DM | 2021-10-05 | 2021-10-05 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON KENNETH ERLAND | See Remarks | A - Grant | — | +89.6K | 89.6K | New | — |
Purchase Sale Sale after option exercise All abbreviations